Top Stories

GSK guts sales amid Avandia woes

, October 24, 2007

GlaxoSmithKline is eliminating around 1,000 sales positions as part of a plan to save $1.4 billion by 2010 through job and plant cuts.
 

Lilly suspends small studies of pipeline drug prasugrel

October 25, 2007

Eli Lilly said it is suspending two small studies of its most promising pipeline candidate, the blood-thinner prasugrel, after data raised concerns about the dosage used in certain patient groups.
 

J&J's Cordis seeks to boost Cypher stent with DTC ads

October 25, 2007

With Abbott and Medtronic crowding into a market it has long split with Boston Scientific, Johnson & Johnson's Cordis is looking to raise the profile of its Cypher stent with a consumer advertising campaign - a possible first for the category.
 

Sponsored Link

Extend Your Reach with About.com Health

About.com Health delivers a robust audience of 7 million uniques each month who come for relevant health information in more than 80 in-depth topic areas. About.com Health delivers a high quality audience: a high concentration of women between the ages of 25-54 - higher than other health web sites - and an audience that goes online more frequently for health information. To reach this healthy audience, contact Michael Frick at mfrick@about.com or find out more at humanexperience.about.com.

In Other News

Seeing potential across the pond, IPG adds UK agency to Integrated

October 25, 2007

Brand(x), a UK brand consultancy and advertising/PR agency, will be run by Integrated Communications Corp. (ICC), following the recent purchase of the agency by Interpublic Group.
 

Lunesta spots most recalled in study of DTC TV ads

October 24, 2007

DTC ads for Sepracor's sleeping pill Lunesta were recalled over 50% more than the average new prescription ad launched this past TV season, according to a recent study conducted by IAG Research.
 

Awards event set to break all records

October 16, 2007

It's official: the MM&M Awards 2007 presentation event will be the biggest and best ever.
 

Product news

October 25, 2007

The FDA has granted marketing approval to Genzyme for its Renvela treatment for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
 

People news

October 25, 2007

Bridge Pharmaceuticals, a contract research organization providing preclinical drug development services in the US and China, announced the appointment of Vincent Lagrotteria to VP of global sales and marketing.
 

Company news

October 25, 2007

Eisai hosted a dedication ceremony to commemorate the opening of its newly constructed US corporate headquarters in Woodcliff Lake, NJ.
 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.